When to Start ART
When to Start ART?
Increased Risk of AIDS-defining Illnesses Seen Even at CD4 Counts of 500-750
- Details
- Category: When to Start ART?
- Published on Wednesday, 28 August 2013 00:00
- Written by Liz Highleyman
HIV positive people with CD4 T-cell counts in the 500-749 cells/mm3 range still have a higher risk of AIDS-defining illnesses -- especially cancers -- compared to those with more than 1000 cells/mm3, although the risk is quite low, according to a study published in the August 6, 2013, advance edition of Clinical Infectious Diseases. These findings offer further evidence of the benefits of prompt antiretroviral treatment.
IAS 2013: Meta-analysis Finds Early HIV Treatment Reduces Risk of AIDS and Death
- Details
- Category: HIV Treatment
- Published on Wednesday, 24 July 2013 00:00
- Written by Liz Highleyman
A meta-analysis of more than 30 studies found that starting antiretroviral therapy with a CD4 T-cell count above 350 cell/mm3 was associated with a lower risk of progression to AIDS or death, according to a poster presented at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur.
IAS 2013: Conference Opens with Focus on Aging, Global Guidelines, Drug Users
- Details
- Category: HIV Treatment
- Published on Sunday, 30 June 2013 00:00
- Written by Liz Highleyman
The 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) kicked off Sunday in Kuala Lumpur, Malaysia. Highlights of the first day included the release of new World Health Organization (WHO) antiretroviral therapy guidelines, a high-level panel on drug policy and public health, and a keynote address on HIV and aging.
IAS 2013: Intensive ART During Primary HIV Infection Lowers Viral Reservoir
- Details
- Category: HIV Treatment
- Published on Wednesday, 24 July 2013 00:00
- Written by Liz Highleyman
Starting intensive antiretroviral therapy (ART) with a 5-drug regimen during the earliest stages of HIV infection can result in lower levels of virus in resting T-cell reservoirs, leading to improved immune function and potentially a better chance at a functional cure, according to studies presented at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur.
IAS 2013: WHO Issues New HIV Recommendations Calling For Earlier Antiretroviral Initiation
- Details
- Category: HIV Treatment
- Published on Sunday, 30 June 2013 00:00
- Written by Leslie Odendal
New HIV treatment guidelines by the World Health Organization (WHO) launched today at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Kuala Lumpur recommend offering antiretroviral therapy to all HIV positive people at CD4 T-cell counts below 500 cells/mm3.
More Articles...
- Very Early HIV Treatment May Delay Disease Progression, Raise CD4 Count
- AIDS 2012: More People Starting HIV Treatment, Lower Viral Load in NA-ACCORD Study
- AIDS 2012: Incomplete CD4 T-Cell Response to ART Raises Mortality Risk
- AIDS 2012: HPTN 052 Continues to Show Clinical Benefits of Earlier Antiretroviral Therapy
Web Design and Development by